FDA advisers vote in support of Paxlovid approval for Covid-19 treatment in high-risk adults
By Janelle Chavez, CNN Advisers to the US Food and Drug Administration voted 16-1 on Thursday in support of full approval of Paxlovid, stating that the benefits outweigh the risks of the drug for treatment of mild to moderate Covid-19 in adults who are at high risk for severe disease, including hospitalization and death. Before
Continue Reading